Yu Chen

Ms. Yu Chen

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2020 in Physical Chemistry Chemical Physics
Verified
Journal Article
Closed access
PDF file
YCYu Chen
Yu Chen
YZYongxiang Zheng
Yongxiang Zheng
PFPedro Fong
Pedro Fong
SMShengjun Mao
Shengjun Mao
QWQiantao Wang
Qiantao Wang
The correct conformation had lower MM/GBSA binding free energy in longer MD simulations for each FGFR1 inhibitor.

22 October 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
TNTheresa Noonan
Theresa Noonan
KDKatrin Denzinger
Katrin Denzinger
VTValerij Talagayev
Valerij Talagayev
YCYu Chen
Yu Chen
KPKristina Puls
Kristina Puls
GWGerhard Wolber
Gerhard Wolber
G protein-coupled receptors (GPCRs) are amongst the most pharmaceutically relevant and well-studied protein targets, yet unanswered questions in the field leave significant gaps in our understanding of their nuanced structure and function. Three-dimensional pharmacophore models are powerful computational tools in in silico drug discovery, presenting myriad opportunities for the integration of GPCR structural biology and cheminformatics. This review highlights success stories in the application of 3D pharmacophore modeling to de novo drug design, the discovery of biased and allosteric ligands, scaffold hopping, QSAR analysis, hit-to-lead optimization, GPCR de-orphanization, mechanistic understanding of GPCR pharmacology and the elucidation of ligand–receptor interactions. Furthermore, advances in the incorporation of dynamics and machine learning are highlighted. The review will analyze challenges in the field of GPCR drug discovery, detailing how 3D pharmacophore modeling can be used to address them. Finally, we will present opportunities afforded by 3D pharmacophore modeling in the advancement of our understanding and targeting of GPCRs.

14 September 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
TNTheresa Noonan
Theresa Noonan
KDKatrin Denzinger
Katrin Denzinger
VTValerij Talagayev
Valerij Talagayev
YCYu Chen
Yu Chen
KPKristina Puls
Kristina Puls
GWGerhard Wolber
Gerhard Wolber
G protein-coupled receptors (GPCRs) are amongst the most pharmaceutically relevant and well-studied protein targets, yet unanswered questions in the field leave significant gaps in our understanding of their nuanced structure and function. 3D pharmacophore models are powerful computational tools in silico drug discovery, presenting myriad opportunities for the integration of GPCR structural biology and cheminformatics. This review highlights success stories in the application of 3D pharmacophore modeling to de novo drug design, discovery of biased and allosteric ligands, scaffold hopping, QSAR analysis, hit-to-lead optimization, GPCR de-orphanization, mechanistic understanding of GPCR pharmacology and elucidation of ligand-receptor interactions. Furthermore, advances in the incorporation of dynamics and machine learning will be highlighted. The review will analyze challenges in the field of GPCR drug discovery, detailing how 3D pharmacophore modeling can be used to address them. Finally, we will present opportunities afforded by 3D pharmacophore modeling in the advancement of our understanding and targeting of GPCRs.

11 February 2019 in Petroleum Science and Technology
Verified
Journal Article
Closed access
CYChengang Yang
Chengang Yang
ZQZongjie Quan
Zongjie Quan
YCYu Chen
Yu Chen
权朱权 朱
权 朱
JWJianli Wang
Jianli Wang
XLXiangyuan Li
Xiangyuan Li
In this work, three kinds of ANNs are employed to predict the pyrolysis behavior of n-decane. Six-fold cross validation method is adopted to optimize the key parameter of ANNs and evaluate the performance of ANNs. The results indicate that RBFN has best performance in predicting the species distribution and all ANNs have good performance in predicting the bulk temperature. Meanwhile, these results reveal that all ANNs are more suitable for predicting products with high mass fraction than those with less mass fraction, whose errors are also acceptable.

1 October 2025 in ChemRxiv
Verified
Preprint
Open access
PDF file
OHOleksandra Herasymenko
Oleksandra Herasymenko
MSMadhushika Silva
Madhushika Silva
GCGalen J. Correy
Galen J. Correy
AAAbd Al-Aziz A Abu-Salehb
Abd Al-Aziz A Abu-Salehb
SASuzanne Ackloo
Suzanne Ackloo
MSMatthieu Schapira
Matthieu Schapira
The third Critical Assessment of Computational Hit-finding Experiments (CACHE) challenged computational teams to identify chemically novel ligands targeting the macrodomain 1 of SARS-CoV-2 Nsp3, a promising coronavirus drug target. Twenty-three groups deployed diverse design strategies to collectively select 1739 ligand candidates. While over 85% of the designed molecules were chemically novel, the best experimentally confirmed hits were structurally similar to previously published compounds. Confirming a trend observed in CACHE #1 and #2, two of the best-performing workflows used compounds selected by physics-based computational screening methods to train machine learning models able to rapidly screen large chemical libraries, while four others used exclusively physics-based approaches. Three pharmacophore searches and one fragment growing strategy were also part of the seven winning workflows. While active molecules discovered by CACHE #3 participants largely mimicked the adenine ring of the endogenous substrate, ADP-ribose, preserving the canonical chemotype commonly observed in previously reported Nsp3-Mac1 ligands, they still provide novel structure-activity relationship insights that may inform the development of future antivirals. Collectively, these results show that multiple molecular design strategies can efficiently converge on similar effective molecules.